Archives

by in
Entry Author Date Location
Tokai, Chasing the Field in Prostate Cancer, Files For IPO 08/12/14 Boston
While Protesters Rage Against Tech Giants, Biotech Drives Quietly By 08/12/14 National
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
T2 Biosystems Sputters Through IPO Queue, Raises $57M 08/07/14 Boston
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Enumeral Raises $21.5M, Heads to the OTC Via Reverse Merger 08/04/14 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan 07/31/14 San Francisco
To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed 07/29/14 National
Emulate Scores $12M to Shake Up Drug Testing With Organs on Chips 07/28/14 Boston
Sarepta Abruptly Fires CSO and RNA Vet Krieg 07/24/14 Boston
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
Xconomy Launches in Raleigh-Durham—10th Cluster in Our Network 07/24/14 National
J&J Immunology Exec on Investing at the Crossroads of the Microbiome 07/24/14 National
Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs 07/22/14 Boston
Cellectar, an OTC Stock, Eyes Nasdaq Jump to Boost Profile, Prospects 07/22/14 Wisconsin
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
Big Late-Stage Deals and Unicorns Drive U.S. Venture Activity Higher 07/10/14 National
Synchroneuron Nets $20M to Combat Drug-Induced Movement Disorder 07/02/14 Boston
Ex-Genentecher Kelsey Grabs Reins at Moderna’s Onkaido Therapeutics 07/01/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
Langer, Led Zeppelin, and Hookups: Three Days Behind the BIO Scenes 06/27/14 San Diego
Page 2 of 86 « previous page · next page »